Inventor · Cranford, NJ, US

Xing Dai

46Patents

3h-index

87Co-inventors

66Inventor score

Filing activity: Apr 1, 1986 → Nov 22, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9718818B2	Compounds inhibiting leucine-rich repeat kinase enzyme activity	Chemistry; Metallurgy	21	Active
US4678847A	Process for preparing a terpolymer of tetrafluoroethylene, ethylene and a third monomer	Chemistry; Metallurgy	6	Expired
US9573939B2	Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases	Emerging Cross-Sectional Technologies	6	Active
US11091481B2	Heterocyclic compounds, preparation and methods and uses thereof	Chemistry; Metallurgy	3	Active
US10647724B2	Selective estrogen receptor degraders and uses thereof	Chemistry; Metallurgy	3	Active
US11205284B2	Vehicle-mounted camera pose estimation method, apparatus, and system, and electronic device	Physics	3	Active
US10980807B2	Inhibitor of indoleamine-2,3-dioxygenase (IDO)	Chemistry; Metallurgy	2	Active
US8361959B2	Spiro-imidazolone derivatives as glucagon receptor antagonists	Chemistry; Metallurgy	2	Active
US11241418B2	Salts of selective estrogen receptor degraders	Chemistry; Metallurgy	2	Active
US9549917B2	Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases	Emerging Cross-Sectional Technologies	1	Active
US10689401B2	C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use	Chemistry; Metallurgy	1	Active
US10047098B2	C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use	Human Necessities	1	Active
US11014936B2	Selective estrogen receptor degraders and uses thereof	Chemistry; Metallurgy	1	Active
US12246020B2	Heterocyclic compounds, preparation methods and uses thereof	Chemistry; Metallurgy	0	Active
US12187736B2	Selective estrogen receptor degraders and uses thereof	Chemistry; Metallurgy	0	Active
US9242998B2	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C	Human Necessities	0	Active
US11339127B2	Salt forms of URAT-1 inhibitors	Chemistry; Metallurgy	0	Active
US11069088B2	Visual positioning method and apparatus, electronic device, and system	Physics	0	Active
US10954240B2	Compounds inhibiting leucine-rich repeat kinase enzyme activity	Chemistry; Metallurgy	0	Active
US12110289B2	Heterocyclic compounds, preparation methods and uses thereof	Chemistry; Metallurgy	0	Active
US10604534B2	C5-C6-oxacyclic fused iminothiadiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use	Human Necessities	0	Active
US9745324B2	Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use	Chemistry; Metallurgy	0	Active
US11691981B2	Heterocyclic compounds, preparation methods therefor, and methods of uses thereof	Chemistry; Metallurgy	0	Active
US9364482B2	Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases	Chemistry; Metallurgy	0	Active
US9243002B2	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.